Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Expression method of recombinant human insulin, special expression vector, engineering bacteria and application

A recombinant human insulin and expression vector technology, applied in the biological field, can solve the problems of disturbing the balance of the intestinal micro-ecosystem, not being able to have a selection marker-resistance gene, adverse effects on normal flora, etc.

Active Publication Date: 2018-01-30
WUHAN ZHENFU PHARMA CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In order to fully comply with the true food-grade lactic acid bacteria engineering bacteria, in addition to the food-grade host bacteria, the vectors used must also meet the food-grade requirements, that is, they cannot have the screening markers used by most expression vectors— Resistance genes, because due to the existence of resistance genes, it is possible to have adverse effects on the normal flora of the intestinal tract of animals or humans, disrupting the balance of their normal intestinal micro-ecological system

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Expression method of recombinant human insulin, special expression vector, engineering bacteria and application
  • Expression method of recombinant human insulin, special expression vector, engineering bacteria and application
  • Expression method of recombinant human insulin, special expression vector, engineering bacteria and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1: Synthesis of the recombinant human insulin coding gene. In order to ensure the accuracy of the final coding sequence and the smooth development of subsequent experiments, the recombinant human insulin coding gene (SEQ ID NO: 1) was commissioned to be synthesized by Shanghai Sangon Biotechnology Co., Ltd., and the obtained product contained The plasmid pMD18T-INS of the recombinant gene.

Embodiment 2

[0036] Example 2: Construction of Recombinant Human Insulin Inducible Surface Display Expression Vector and Engineering Bacteria

[0037] see figure 1 Constructing recombinant human insulin inducible surface display expression vector, the specific process includes the following steps:

[0038] 1. Construction of vector pMRF01 containing recombinant human insulin coding sequence

[0039] Amplification primers were designed according to the recombinant human insulin coding sequence, and NcoI and KpnI restriction sites were introduced into the upstream and downstream primers respectively. The primer sequences are as follows:

[0040] Upstream primer P1: 5'-CATG CCATGG CATTTGTTAACCAACATTTATGTGGTTCAC-3' (the underlined part is the NcoI recognition site, and the italic part is the matching base introduced without avoiding the change of the reading frame)

[0041] Downstream primer P2: 5'-GG GGTACC GTTACAGTAGTTCTCAAGTTGATATAATGAACA-3' (the underlined part is the KpnI recognitio...

Embodiment 3

[0055] Example 3: Cell wall display expression of recombinant human insulin in lactic acid bacteria and identification of expression products

[0056] 1. Induced expression of recombinant human insulin in lactic acid bacteria

[0057] Inoculate the corresponding expression engineered bacteria L.lactisNZ3900 / pMRF5018 successfully constructed in Example 2 into 5ml of LM17 medium, culture it overnight at 30°C, and inoculate the culture into freshly prepared LM17 at a ratio of 1:50 the next day , cultured statically at 30°C to OD 600 About 0.2-0.5, then add nisin (Nisin) with a final concentration of about 0.1-100ng / ml to the culture for induction, and culture at 30°C for 3-12 hours. At the same time, the L.lactisNZ3900 empty strain and the expression engineering bacteria L.lactisNZ3900 / pMRF5018 were not induced as two groups of control groups.

[0058] The bacterial cell pellet was collected by centrifugation, and was washed with pre-cooled PBS buffer (NaCl 137mmol / L, KCl2.7mmo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an expression method of recombinant human insulin, a special expression vector, engineering bacteria and application. This expression method can induce the expression of recombinant human insulin gene in food-grade lactic acid bacteria and display recombinant human insulin on the surface of lactic acid bacteria. The engineering bacteria, expression vector and inducer used in this expression method all meet the requirements of food grade, avoiding the The presence of resistance genes on vectors and the potential harm caused by non-food-grade inducers, etc. The lactic acid bacteria engineering bacteria containing cell wall display insulin obtained by the present invention can stimulate NOD mice to produce recombinant human insulin-specific antibodies, significantly increase the level of cytokine IL-4 related to immune tolerance, and induce immune tolerance. The induced lactic acid bacteria engineered bacteria can be used as an oral vaccine for type 1 diabetes after being made into bacterial preparations, without the need for tedious post-processing such as purification, and has broad application prospects.

Description

【Technical field】 [0001] The invention relates to the field of biotechnology, in particular to a method for expressing recombinant human insulin, a special expression vector, engineering bacteria and its application. 【Background technique】 [0002] Diabetes is a chronic disease caused by insulin deficiency or deficiency caused by congenital or acquired factors. This lack of insulin leads to elevated blood sugar levels which can lead to damage to the body, especially blood vessels and nerves. Polydipsia, polyuria, polyphagia, and weight loss are typical symptoms of diabetes. In severe cases, ketone poisoning and chronic diseases of various organs may also occur. [0003] There are two main types of diabetes: type I and type II. Type I diabetes (Type I diabetes mellitus, T1DM) is an autoimmune disease. The pancreas of the patient is destroyed by the immune system, resulting in an absolute lack of insulin. Blood sugar is stable. Type II diabetes (Type II diabetes mellitus, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/17C12N15/74C12N1/21C12P21/02A61K38/28A61P3/10C12R1/46
Inventor 王业富毛瑞峰
Owner WUHAN ZHENFU PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com